Aims: The aim of this study was to evaluate the antioxidant status and oxidative stress biomarkers in the blood of children and teenagers with Down syndrome. Main methods: The analysis of enzymatic antioxidant defenses, such as the activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione transferase (GST), non-enzymatic antioxidants, such as levels of reduced glutathione (GSH), uric acid (UA) and vitamin E, as well as oxidative damage indicators, such as protein carbonyls (PC) levels and lipoperoxidation (TBARS), of DS individuals (n = 20) compared to healthy controls (n = 18). Except the vitamin E was measured by HPLC, all other markers were measured spectrophotometrically. Key Findings: Antioxidant enzymes analysis showed significant increases in the SOD (47.2%), CAT (24.7%) and GR (49.6%) activities in DS subjects. No significant difference in GPx activity was detected while GST activity (61.2%) was decreased, and both responses may be consequence of the depletion of GSH (24.9%) levels. There were no significant differences in TBARS levels, while PC levels showed decreased (31.7%) levels compared to healthy controls, which may be related to the increase (16.1%) found in serum UA. Levels of vitamin E showed no significant differences between DS individuals compared to controls. Significance: The results revealed a systemic pro-oxidant status in DS individuals, evidenced by the increased activity of some important antioxidant enzymes, together with decreased GSH levels in whole blood and elevated UA levels in plasma, probably as an antioxidant compensation related to the redox imbalance in DS individuals.
Introduction
The incidence of Down syndrome (DS) is approximately 1/1.000 to 1/1.200 of live births (World Health Organization, 2007) . DS is caused by a chromosomal aberration involving total or partial trisomy of chromosome 21 in humans. The presence of an extra copy of chromosome 21 affects several phenotypic and physiological features. Mental retardation associated with DS is accompanied by learning and memory deficits, a high rate of repetitive behaviors and impairments in adaptive behavior. In addition, the brain abnormalities observed in DS have been linked to an inherent oxidative stress, for example, characteristics of accelerated aging and high incidence of hyperactivity, with accompanying attention deficits (Ribeiro et al., 2003; Shichiri et al., 2011) .
In a region of the distal part of chromosome 21 (21q22 band), which is tripled and known as the critical region of DS, the superoxide dismutase 1 (SOD1) gene is located (Antonarakis, 1998) . SOD1 catalyzes the conversion of superoxide anion (O 2 •− ) into hydrogen peroxide (H 2 O 2 ), two of the main reactive oxygen species (ROS) continuously generated mainly in the aerobic cells in the mitochondria (Halliwell and Gutteridge, 2006) . H 2 O 2 in turn is degraded by catalase (CAT) and glutathione peroxidase (GPx) into water and molecular oxygen. Hydrogen peroxide produced in excess is a result of increased SOD1 activity without the concomitant increase of complementary antioxidant defense mechanisms, such as CAT and GPx activity (Halliwell and Gutteridge, 2006 ). The accumulation of endogenous H 2 O 2 , which is highly diffusible and relatively stable, therefore is able to generate other deleterious ROS through the Haber-Weiss-Fenton reactions, in this way damaging important cellular components, oxidizing biomolecules such as amino acid residues, proteins, lipids and DNA (Halliwell and Gutteridge, 2006) . The objective of this study is to evaluate the antioxidant status through oxidative stress biomarkers present in the blood of children and adolescents with DS compared to healthy controls, taken into consideration the relatively paucity of information in the specific literature (Pallardó et al, 2006; Lott et al., 2011; Komatsu et al., 2013) , especially regarding children with this syndrome.
Subjects and methods

Study design
Eighteen healthy children (average age of 6.7 ± 3.0 years showing inflammatory markers within normal ranges) without DS (10 males and 8 females; 3-12 years) were recruited from the Hospital Infantil Joana de Gusmão of Florianópolis, Santa Catarina, south Brazil, to constitute the control group. The participants with DS exhibited an average age of 7.7 ± 3.18 years, and most individuals concentrated in the age group 6-10 years (65%). These patients followed criteria for inclusion such as age between 3 and 14 years without the presence of illnesses associated with systemic diseases, and were not participating in other studies. Patients taking medication or food supplements were excluded. The twenty subjects with DS were recruited from two local organizations for children with DS ("Associação Amigos Down" and "Associação de Pais e Amigos dos Excepcionais -APAE"). The study protocol was approved by the Ethics Committee of UFSC according to the national and international guidelines for research involving human subjects (Resolution No. 1996 of the National Health Council), which regulate experiments involving human subjects (local protocol CEP N. 2112/2011). All patients received information about the study and their parents signed the free and informed consent form.
Sample preparation
The samples were obtained from the antecubital vein in chilled tubes containing EDTA as anticoagulant, or without EDTA to obtain serum. Immediately after blood collection a blood fraction (200 μl) was precipitated in trichloroacetic acid (TCA 12%, 1:4 v/v) for reduced glutathione (GSH) assays. The remaining blood was centrifuged at 1500 g for 10 min to separate the red cells from plasma. For enzymatic assays, the red cells were diluted in distilled water (1:4) and hemolysis was carried out by freezing and thaw procedure. After this, plasma, serum and the acid extracts were stored in liquid nitrogen (−170°C) until analysis of the parameters. Enzymatic evaluations were carried out in hemolysates, while the contents of GSH were obtained in whole blood acid extracts. Thiobarbituric acid reactive substances (TBARS), protein carbonyl and vitamin E contents were examined in plasma. The inflammatory parameters were analyzed in plasma (data not shown).
Antioxidant enzyme assays
Catalase activity was determined by measuring the decrease in a freshly prepared 10 mM hydrogen peroxide solution at 240 nm (Aebi, 1984) . Superoxide dismutase activity was measured at 480 nm according to the method of epinephrine autoxidation (Misra and Fridovich, 1972) and modified by Boveris et al. (1983) . Glutathione reductase activity was measured at 340 nm, by measuring the rate of NADPH oxidation (Calberg and Mannervik, 1985) . Glutathione peroxidase was assayed at 340 nm, through the glutathione/NADPH/glutathione reductase system, by the reduction of terc-butylhydroperoxide (Flohé and Gunzler, 1984) . Glutathione-S-transferase activity was determined at 340 nm using CDNB (1-chloro-2,4-dinitrobenzene) as substrate and a 0.15 M GSH concentration (Habig et al., 1976) . All enzymatic activities were expressed in milliliters of whole blood.
Reduced glutathione (GSH) assay
Reduced glutathione (GSH) was measured at 412 nm (Beutler et al., 1963) , using the reagent DTNB (2-dithionitrobenzoic acid). After being centrifuged at 3000 g for 5 min, the supernatants from the acid extracts were added to 0.25 DTNB in 0.1 M sodium phosphate buffer pH 8.0, and the formation of the corresponding thiolate anion was immediately determined. Determinations were expressed in micromoles per milliliter of whole blood, using ε = 14.1 mmol
Determination of serum uric acid (UA)
Serum concentration of uric acid was measured spectrophotometrically using Analisa® kits through a colorimetric method, based on the oxidation of uric acid, uricase producing a red chromophore measured at 520 nm.
Vitamin E assay
Determination of vitamin E in plasma was carried out by high performance liquid chromatography (HPLC) with UV detection at 292 nm (Nicoletti et al., 2001 ). An aliquot of 100 μl of plasma was added to 100 μl of ethanol and vortexed for 10 s and added to 100 μl of hexane, and again vortexed for 45 s. After centrifugation (8000 g) for 5 min, 75 μl of the supernatant (hexane) was transferred to an Eppendorf and the hexane was evaporated by nitrogen flow. Then 125 μl diethylether and 375 μl methanol were added and this mixture was injected in HPLC. Isocratic elution was carried out with methanol using a flow rate of 1 ml·min
. Samples were measured in duplicate and plasma concentrations of α-tocopherol were determined through a standard curve and expressed as μmol vitamin E ml −1 .
Lipid peroxidation assessment (TBARS levels)
Lipid peroxidation in plasma was determined spectrophotometrically at 535 nm in triplicate by the thiobarbituric acid method (TBARS) (Bird and Draper, 1984) . Briefly, plasma was precipitated with trichloroacetic acid (TCA) followed by the incubation with TBA 0.76%, at 100°C, for 60 min in a phosphate buffer at pH 7.4 (60 mM Tris-HCl and 0.1 mM DPTA), at high (100°C) temperature, the samples were then centrifuged (5 min, 1500 g) and the absorbance of the pink chromophore was measured, using ε = 1.56 × 10 5 M −1 cm −1
. The values were expressed in nmol TBARS ml −1 .
Protein carbonyls (PC)
Oxidative damage promoted by protein carbonylation was determined using 100 μl of plasma, which were added to 600 μl DPNH (2,4-dinitrophenyl-hydrazine). Ethanol/ethyl acetate (1:1; v:v) was used to remove hydrazine excess. After this, incubation with guanidine chloride (600 μl) was performed and the maximum carbonyl absorbance in the range of 360-370 nm was recorded (Levine et al., 1990) . The total protein concentration was determined by the method of Lowry et al. (1951) , using albumin as a standard. The concentration of carbonyl protein was expressed in nmol·mg −1
. All measurements were carried out in triplicate.
Chemicals
All the chemicals and solvents used were of analytical grade and purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Statistical analysis
Data were expressed as means ± SEM. Unpaired Student t test was used to compare the different groups. The coefficient of Pearson was used to evaluate correlations among GST and GPx activity and GSH concentrations. Minimal values of p b 0.05 were considered statistically significant. Fig. 1 . Enzymatic activity in hemolysates of (A) superoxide dismutase (SOD), (B) catalase (CAT), (C) glutathione peroxidase (GPx), (D) glutathione reductase (GR), and (E) glutathione Stransferase (GST). Contents of (F) reduced glutathione (GSH) in whole blood extracts, contents of (G) uric acid (UA) in serum, contents of (H) vitamin E (vit E), (I) substances that react with thiobarbituric acid (TBARS), and (J) protein carbonyls (PC) in plasma, in Down syndrome subjects (n = 20). Asterisks (*) (***) mean statistical differences for p b 0.05and p b 0.001, compared to controls (n = 18), respectively.
Results
There was no significant difference between the body mass index (BMI) of patients with DS (17.9 ± 0.76) compared to controls (16.9 ± 0.61). The values of SOD activity in individuals with DS showed increased activity (47.2%; values around 120 U SOD·ml − 1 ) compared with the activity of SOD found in healthy individuals (~63 U SOD·ml − 1 ) (Fig. 1A) . Catalase activity also showed a significant (24.7%) increase (~157 μmol·min − 1 ·ml − 1 ) in DS individuals compared to healthy controls (~118 μmol·min − 1 ·ml − 1 ) (Fig. 1B) . GR also showed a significantly higher activity (49.6%;~1 μmol·min
) in DS patients compared to controls (~0.5 μmol·min (Fig. 1D ). GPx activity in DS patients (~57 μmol·min
) showed no significant difference compared to controls (~59 μmol·min (Fig. 1C) . Contrary to the behavior of the other enzymes examined, GST activity was significantly decreased (61.2%;~43 μmol·min ) (Fig. 1E) . The concentrations of TBARS and vitamin E in plasma also showed no significant difference between the groups. On the other hand, GSH and PC concentrations were significantly decreased (24.9%;~1.3 mmol·ml −1 and 31.7%;~0.03 μmol·mg
, respectively) in DS subjects compared to controls (~1 mmol·ml ) showed a significant increase of 16.1% compared to subjects from the control group (~3 mg·dl −1 ) (Fig. 1G ).
Discussion
The results related to the different biomarkers of oxidative stress obtained in the present study clearly revealed a systemic pro-oxidant condition in the blood of DS subjects. The main findings are the upregulation found in most of the activity of antioxidant enzymes in hemolysates as well as the GSH depletion found in whole blood together with the increased contents detected in serum urate values. Several studies carried out on other human pathologies have shown that the augmented activities found in distinct antioxidant enzymes are a physiological response to compensate the persistent oxidative insult, which is also present in DS subjects (Halliwell and Gutteridge, 2006) .
The enhanced (47.2%) SOD1 activity detected in the present study is expected in DS patients and also in genetically modified laboratory animals that mimic the overexpression of this important antioxidant enzyme, which is located in the region 21q22 of the chromosome 21 (Brooksbank and Balazs, 1984; Epstein et al., 1987) .
Nevertheless, the chronic SOD1 overexpression in all cells that characterizes the trisomy 21 subjects and the consequent overgeneration of endogenous hydrogen peroxide apparently is not adequately compensated by the relatively modest upregulation of catalase. Therefore, this chronic imbalance between the levels of both important antioxidant enzymes (SOD/CAT) and their corresponding substrates (O 2
•− /H 2 O 2 ), thereby favoring the generation of the most deleterious hydroxyl radical (HO • ), is apparently the basis for DS disturbances (Ani et al., 2000; Vasconcelos et al., 2007) , such as neurological and hematological abnormalities as well as the accelerated aging process (Aguilar-da-Silva et al., 2003) .
Catalase also showed enhanced activity (24.7%) in DS subjects compared to healthy controls. This CAT upregulation is expected in DS subjects (Pastor et al., 1998) , considering that beside the general intervention of glutathione peroxidase on hydroperoxide detoxification, catalase is specifically able to decompose normal levels of hydrogen peroxide generation into water and molecular oxygen (Halliwell and Gutteridge, 2006) . However, as mentioned before, such increased activity seems not to be sufficient to avoid the excess of H 2 O 2 generated by the overexpression of SOD1 in all cells of trisomy 21 subjects, in this way contributing to a persistent oxidative stress found in DS subjects.
The cellular response involving GPx activity in the erythrocytes of DS subjects is controversial (Kedziora and Bartosz, 1988) . As found in the present work, other related studies also reported no alterations in this important antioxidant enzyme compared to healthy individuals (Brooksbank and Balazs, 1983; Vertongen et al., 1984) . However, similar studies revealed enhanced GPx activity, both in humans and also in laboratory animals (Ceballos et al., 1988; Pastor et al., 1998) . To detoxify hydroperoxides, GPx needs the participation of GSH as a cofactor leading to the formation of its oxidized form (GSSG), which is very toxic to cells (Chance et al., 1979) . The erythrocytic GPx is the main enzyme in H 2 O 2 detoxification in physiological conditions, while CAT upregulation occurs when higher levels of this ROS are generated, as found in all cells of DS subjects (Halliwell and Gutteridge, 2006) .
GSH depletion is usually reported in DS subjects (Muchová et al., 2001; Pastore et al., 2003; Hamed et al., 2011) , and it was also detected in the present study. Such depletion may also contribute to the relatively low GPx activity, which is a limiting factor to its function (Halliwell and Gutteridge, 2006) . Under oxidative stress the ratio between the reduced and oxidized form of glutathione (GSH:GSSG) is critical for the loss of mitochondrial function and cellular viability (Meister and Anderson, 1983; Schulz et al., 2000) . Beside its crucial role as a general antioxidant including HO
• detoxification, the other main role of the GSH cycle is to support GPx and GST activities constantly supplying and maintaining a high concentration (approximately in the range of 1-10 mM) pool of this important tripeptide, apparently in all aerobic cells (Wilhelm Filho et al., 2000) . Furthermore, GSH also participate in vitamins E and C regeneration, amino-acid transport, immunological functions, cellular signaling, among other important functions (Halliwell and Gutteridge, 2006) , which are jeopardized in DS subjects, thereby contributing to the manifestation of this syndrome.
The results obtained in the present study showed enhanced activity of GR in DS subjects in accordance with a previous related work (Pastor et al., 1998) . GR is a flavoprotein that allows the continuous conversion of GSSG to GSH, through the oxidation of NADPH to NADP (Meister and Anderson, 1983) . The GR upregulation found in the blood of DS subjects probably reflects the necessity to counteract the oxidative stress present in their blood, trying to restore the high tissue concentrations (~99%) usually reported for normal cell metabolism in all aerobic organisms (Wilhelm Filho et al., 2000) .
Similar to the relatively low GPx activity detected in the present study, the decreased activity found in erythrocytic GST from DS subjects may be attributable to the GSH depletion. Weak negative correlations measured through the coefficients of Pearson were found between GST activity (−0.30) and GPx activity (−0.15) GSH concentrations, probably indicating the use of GSH by both enzymes. The super-family of distinct isoforms of glutathione S-transferase, beyond their role in xenobiotic detoxification, also helps in the detoxification of endogenous hydroperoxides continuously generated through cellular lipoperoxidation processes (Danielson and Mannervik, 1985; Hayes and Mclellan, 1999) . In this regard, the relatively low GSH levels available for GST and GPx activities, which are probably limiting their responses to the persistent oxidative stress present in DS subjects, may be responsible for exacerbating such oxidative insult.
As found in other studies (Meguid et al., 2010; Campos et al., 2011) , no alterations were found regarding lipid damage by ROS (TBARS levels), as well as protein damage (PC levels), which were decreased in DS subjects compared to controls. However, other studies revealed increased damage to proteins, lipids and DNA (Brooksbank and Balazs, 1984; Ani et al., 2000) , including high in vitro lipid oxidation in the brain of fetuses (Le Pecheur et al., 2005) , despite the fact that DS children possess higher levels of monounsaturated fatty acids compared to healthy children (Santos, 2006) , an aspect that may predispose the latter children to potentially high oxidation processes. In the only other study that reported protein damage associated to DS, Campos et al. (2010) found higher oxidation levels in diTyr (dityrosine) in DS children when compared to their non-DS brothers.
The relatively high levels of urate, a well known and powerful antioxidant (Nagiová et al., 2000; Campos et al., 2011) found in the serum and urine of apparently all DS children, young and adults (Pallardó et al, 2006; Campos et al., 2010 Campos et al., , 2011 , may reflect an antioxidant compensation for the persistent oxidative insult promoted by the disease. Urate is able to reduce the peroxil radical (ROO • ) to hydroperoxide (ROOH), blocking its transformation to low-molecular aldehydes, including the toxic and major product of lipoperoxidation, malondyhaldehyde (MDA) (Halliwell and Gutteridge, 2006) . As a consequence, lower levels of MDA/TBARS are expected in DS subjects (Ames et al., 1981; Simão et al., 2008) , as found in the present work and in other related studies.
Vitamin E levels did not show any difference between both studied groups, a result in accordance with other related study (Meguid et al., 2010) . However, in DS patients who were also diagnosed with Alzheimer disease, plasma contents of vitamin E were lower compared with DS patients not showing this neurodegenerative disease (Jackson et al., 2008) . Lockrow et al. (2009) reported that vitamin E supplemented Ts65Dn rats, a murine model of DS, oxidative stress was attenuated by this antioxidant intervention, strongly suggesting that an early antioxidant treatment could be useful (Zana et al., 2007) . This liposoluble chain-breaker protects membranes of cells and organelles and also avoiding LDL oxidation (Halliwell and Gutteridge, 2006) , and requires GSH, ascorbate and coenzime Q10 (ubiquinol) as synergic co-antioxidants (Halliwell and Gutteridge, 2006) . Accordingly, some previous reports showed that the early supplementation of micronutrients such as vitamins E, C and B6, folic acid, zinc, selenium, α-lipoic acid and L-cysteine, is able to prevent or delay cognitive retardment in DS patients (Ani et al., 2000; Thiel and Fowkes, 2005) . However, no cognitive improvement in DS patients after an antioxidant intervention was found (Lott 2011; Lott, 2012) . On the other hand, preliminary results from our laboratory after six months of vitamins E and C intervention indicate a significant attenuation of the systemic oxidative stress in DS patients.
Conclusions
The present study showed that the presence of trisomy 21 in children and adolescents results in significant biochemical changes that contribute to a systemic and exacerbated oxidative stress in the blood of DS patients, in a way similar to that already demonstrated by our group in other chronic diseases where oxidative stress is highlighted (Maçao et al. 2007; Farias et al. 2012) .
